World's Best Scientists 2026 revealed!
Lisa M. Rimsza

Lisa M. Rimsza

D-Index & Metrics

Medicine

D-Index
86
Citations
41131
World Ranking
13879
National Ranking
7047

Overview

Lisa M. Rimsza is affiliated with the Mayo Clinic in the United States and has produced extensive research in the field of medicine, with a strong focus on pathology and forensic medicine, oncology, molecular biology, genetics, and neurology. The scientist's work encompasses a variety of topics, primarily centered on lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, viral-associated cancers and disorders, CNS lymphoma diagnosis and treatment, CAR-T cell therapy research, cancer genomics and diagnostics, and lung cancer treatments and mutations.

The scientist's notable recent publications include:

  • Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001 (2020, Journal of Clinical Oncology)
  • EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity (2020, Blood)
  • MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma (2021, Haematologica)
  • Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2 (2020, American Journal of Clinical Pathology)
  • Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements (2021, Blood Advances)

Frequent coauthors collaborating with Lisa M. Rimsza include:

  • Andrew L. Feldman
  • James R. Cerhan
  • Thomas M. Habermann
  • Elaine S. Jaffe
  • Matthew J. Maurer

The scientist's work is often published in a range of respected journals, with the highest number of publications appearing in:

  • Blood
  • Hematological Oncology
  • Blood Advances
  • American Journal of Clinical Pathology
  • Clinical Lymphoma Myeloma & Leukemia

Lisa M. Rimsza's research is strongly concentrated on lymphoma and related hematological malignancies, investigating molecular pathways, treatment strategies, and the biological characteristics of lymphomas and leukemia.

Best Publications

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    R. Eric Davis;Vu N. Ngo;Georg Lenz;Pavel Tolar

  • Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

    Ryan D Morin;María Méndez-Lago;Andrew J Mungall;Rodrigo Goya

  • Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    Roland Schmitz;George W. Wright;Da Wei Huang;Calvin A. Johnson

  • Oncogenically active MYD88 mutations in human lymphoma

    Vu N. Ngo;Vu N. Ngo;Ryan M. Young;Roland Schmitz;Sameer Jhavar

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

    Christian Steidl;Tang Lee;Sohrab P. Shah;Pedro Farinha

  • Efficacy of lenalidomide in myelodysplastic syndromes.

    Alan List;Sandy Kurtin;Denise J. Roe;Andrew Buresh

  • Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

    Georg Lenz;George W. Wright;N. C.Tolga Emre;Holger Kohlhammer

  • ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project

    Kerry J. Savage;Nancy Lee Harris;Julie Marie Vose;Fred Ullrich

  • Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

    Nathalie A. Johnson;Graham W. Slack;Kerry J. Savage;Joseph M. Connors

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar

  • Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

    Georg Lenz;R. Eric Davis;Vu N. Ngo;Lloyd Lam

  • A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

    William W L Choi;Dennis D. Weisenburger;Timothy Charles Greiner;Miguel A. Piris

  • MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

    Christian Steidl;Sohrab P. Shah;Bruce W. Woolcock;Lixin Rui

  • Cyclin D1-negative mantle cell lymphoma : a clinicopathologic study based on gene expression profiling

    Kai Fu;Dennis D. Weisenburger;Timothy Charles Greiner;Sandeep Dave

  • Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin embedded tissue

    David W. Scott;George W. Wright;P. Mickey Williams;Chih Jian Lih

  • Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.

    Javeed Iqbal;George Wright;Chao Wang;Andreas Rosenwald

  • Methods to Detect P-Glycoprotein-associated Multidrug Resistance in Patients' Tumors: Consensus Recommendations

    William T. Beck;Thomas M. Grogan;Cheryl L. Willman;Carlos Cordon-Cardo

Frequent Co-Authors

Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Andreas Rosenwald
Andreas Rosenwald University of Würzburg
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Elias Campo
Elias Campo University of Barcelona
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Jan Delabie
Jan Delabie University Health Network
German Ott
German Ott Robert Bosch (Germany)
Wing C. Chan
Wing C. Chan City of Hope
Joseph M. Connors
Joseph M. Connors University of British Columbia
Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but aren’t sure about committing to medical school, there are several alternative pathways to explore. Many students choose direct entry msn programs for non-nurses online as a fast route to advanced nursing roles, even if you don’t already have a nursing background.

For those looking for less competitive options, some may want to know whats the easiest nursing program to get into? These programs can reduce barriers and help you start your career sooner. There are also nursing school without teas test options, for applicants who want to skip standardized exam requirements.

Beyond clinical roles, healthcare careers like medical billing and coding offer flexible, in-demand paths. Explore the best medical billing and coding schools online for accredited, affordable programs with financial aid. Each path has unique benefits—consider your interests and professional goals as you decide.

Best Scientists Citing Lisa M. Rimsza

Trending Scientists